

Concert Pharmaceuticals is a biotechnology company utilizing deuterium to develop novel medical candidates. Among its major competitors, Concert Pharmaceuticals is ranked in 11th place for NPS while Merck is 1st, and Biogen is 2nd.Their current market cap is $520.71M